Cargando…

Risk stratification for venous thromboembolism in patients with testicular germ cell tumors

BACKGROUND: Patients with testicular germ cell tumors (TGCT) have an increased risk for venous thromboembolism (VTE). We identified risk factors for VTE in this patient cohort and developed a clinical risk model. METHODS: In this retrospective cohort study at the Medical University of Graz we includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bezan, Angelika, Posch, Florian, Ploner, Ferdinand, Bauernhofer, Thomas, Pichler, Martin, Szkandera, Joanna, Hutterer, Georg C., Pummer, Karl, Gary, Thomas, Samonigg, Hellmut, Beyer, Joerg, Winder, Thomas, Hermanns, Thomas, Fankhauser, Christian D., Gerger, Armin, Stotz, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400272/ https://www.ncbi.nlm.nih.gov/pubmed/28430804 http://dx.doi.org/10.1371/journal.pone.0176283

Ejemplares similares

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
por: Terbuch, Angelika, et al.
Publicado: (2018)

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients
por: Terbuch, Angelika, et al.
Publicado: (2018)

Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients
por: Szkandera, Joanna, et al.
Publicado: (2014)

Long-term cardiovascular complications in stage I seminoma patients
por: Terbuch, A., et al.
Publicado: (2017)

Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study
por: Riedl, Jakob Michael, et al.
Publicado: (2017)

MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients
por: Lembeck, Anna L., et al.
Publicado: (2020)

Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection
por: Stotz, Michael, et al.
Publicado: (2016)

Evaluation of Uric Acid as a Prognostic Blood-Based Marker in a Large Cohort of Pancreatic Cancer Patients
por: Stotz, Michael, et al.
Publicado: (2014)

Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting
por: Riedl, Jakob Michael, et al.
Publicado: (2017)

Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
por: Moik, Florian, et al.
Publicado: (2019)

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation
por: Hofmann, Guenter, et al.
Publicado: (2006)

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
por: Stotz, M, et al.
Publicado: (2014)

Reply: Comment on ‘A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'
por: Szkandera, J, et al.
Publicado: (2013)

A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
por: Absenger, G, et al.
Publicado: (2013)

Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study
por: Posch, Florian, et al.
Publicado: (2017)

Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy
por: Fankhauser, Christian Daniel, et al.
Publicado: (2018)

External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
por: Szkandera, Joanna, et al.
Publicado: (2013)

Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses
por: Pratsinis, Manolis, et al.
Publicado: (2022)

CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors
por: Fankhauser, Christian Daniel, et al.
Publicado: (2019)

Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma
por: Seles, Maximilian, et al.
Publicado: (2016)

Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy
por: Klöckl, Marie-Christin, et al.
Publicado: (2020)

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer: A retrospective analysis
por: Asamer, Eva, et al.
Publicado: (2018)

Evaluation of autoantibodies as predictors of treatment response and immune‐related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan‐cancer study
por: Barth, Dominik A., et al.
Publicado: (2022)

Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer
por: Smolle, Maria A., et al.
Publicado: (2017)

LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy
por: Szkandera, J, et al.
Publicado: (2015)

Excellent survival in relapsed stage I testicular cancer
por: Speicher, Philip, et al.
Publicado: (2023)

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
por: Stotz, M, et al.
Publicado: (2013)

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable as well as inoperable pancreatic cancer
por: Stotz, M, et al.
Publicado: (2013)

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
por: Posch, Florian, et al.
Publicado: (2017)

Frequent PD-L1 expression in testicular germ cell tumors
por: Fankhauser, C D, et al.
Publicado: (2015)

Desmoid Tumor Treated with Polychemotherapy Followed by Imatinib: A Case Report and Review of the Literature
por: Knechtel, Gudrun, et al.
Publicado: (2010)

Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
por: Szkandera, J, et al.
Publicado: (2014)

Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study
por: Barth, Dominik A., et al.
Publicado: (2022)

Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer
por: Seles, Maximilian, et al.
Publicado: (2020)

Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence
por: Christiansen, Ailsa J., et al.
Publicado: (2022)

Oncological and functional outcomes after testis-sparing surgery in patients with germ cell tumors: a systematic review of 285 cases
por: Grogg, Josias Bastian, et al.
Publicado: (2022)

Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil–lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma
por: Dalpiaz, Orietta, et al.
Publicado: (2017)

Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
por: Pichler, M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9079bn293otv9akq9790ghrldr